Efficacy and Safety of SmofKabiven Peripheral Versus Compounded Emulsion
Clinical trial NCT03792087 · COMPLETED
Trial details
- NCT number
- NCT03792087
- Sponsor
- Fresenius Kabi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-21
- Primary completion
- 2018-12-30
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.